| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/31/2005 | US6900192 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 05/31/2005 | US6900161 Azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 05/31/2005 | CA2117209C 2-substituted-5-chlorimidazoles |
| 05/26/2005 | WO2005047899A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | WO2005047267A1 Process for the synthesis of imidazoles |
| 05/26/2005 | WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005047242A2 Compounds containing thiosulfate moieties |
| 05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 05/26/2005 | WO2005047230A1 Bis-cationic compounds and use thereof |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113372 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 05/26/2005 | US20050112693 Screening, biosynthesis of peptides |
| 05/26/2005 | US20050112406 Organometallic complexes and organic electroluminescence device using the same |
| 05/26/2005 | CA2545742A1 Process for the synthesis of imidazoles |
| 05/26/2005 | CA2544983A1 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1533302A1 Histidine derivatives |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |
| 05/25/2005 | EP1532118A2 Imidazole compounds for the treatment of hepatitis c virus infections |
| 05/25/2005 | EP1532117A1 Multi-substituded imidazolines and method of use thereof |
| 05/25/2005 | EP1532108A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/25/2005 | EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 05/25/2005 | EP1531810A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/25/2005 | EP1531674A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | EP0904274B1 Farnesyl transferase inhibitors |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |
| 05/25/2005 | CN1203063C Easter compound, method for preventing and controlling injurious insect and use of said ester compound |
| 05/25/2005 | CN1203062C Purification method of climbazole |
| 05/25/2005 | CN1202819C Intraocular pressure reducing agent |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/24/2005 | US6896891 Non-systemic control of parasites |
| 05/19/2005 | WO2004097406A3 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION |
| 05/19/2005 | WO2004092100A8 Indene derivatives as pharmaceutical agents |
| 05/19/2005 | US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 05/19/2005 | US20050107606 Process for producing optically active sulfoxide derivative |
| 05/19/2005 | US20050107455 Novel tricycloimidazoline derivatives method for production and use thereof as medicaments |
| 05/19/2005 | US20050107454 crystallization of 1-(4-chlorophenoxy)-1-(1H-imidazolyl)-3,3-dimethyl-2-butanone in solvents, then washin and desolventizing; cosmetics: shampoos; fungicides |
| 05/19/2005 | US20050107453 Resolution of 3-amino alkylnitriles |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107433 Process for production of optically active compounds |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050106685 Method of synthesizing polynucleotides using ionic liquids |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/18/2005 | EP1531152A1 Process for purification of climbazol |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1098885B9 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/18/2005 | CN1617857A 2'-halo-3', 5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivative and the use thereof as a drug for curing urinary incontinence |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1617710A Liposome composition for delivery of nucleic acid |
| 05/18/2005 | CN1616435A Process for preparing hydantoin by one-step method |
| 05/18/2005 | CN1616434A Method for producing 1, 3-dimethyl -2-imidazolinone |
| 05/18/2005 | CN1202086C Halogenating agent |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894049 Anticancer agents; water solubility |
| 05/17/2005 | US6893471 For dyeing human hair |
| 05/17/2005 | CA2175456C Method of making highly alkaline solid cleaning compositions |
| 05/12/2005 | WO2005042469A1 Aromatic amino acid labeled with stable isotope, method for incorporating the same into target protein and method for analyzing protein structure using nmr |
| 05/12/2005 | WO2005041853A2 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. |
| 05/12/2005 | WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2 |
| 05/12/2005 | WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 05/12/2005 | WO2004087061B1 Tubulin binding agents and corresponding prodrug constructs |
| 05/12/2005 | WO2004037162A3 Compositions and methods for the treatment of hepatitis c virus infection |
| 05/12/2005 | US20050101785 Reaction of cyano compound with silylalkylisocyanide for active imidazoles |
| 05/12/2005 | US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 05/12/2005 | US20050101763 For use as building blocks in photolithographic solid-phase peptide synthesis; microarrays |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050101642 Niacinamide derivatives as inhibitor of poly(ADP-ribose)polymerase; ranitidine, cimetidine, famotidine, nizatidine as gastric acid secretion control; immunomodulation and suppression of hypersensitivity and inflammatory reaction; IgE mediated allergic reaction; no side effects; virtually non-toxic |
| 05/11/2005 | EP1529530A1 Compounds affecting glucokinase |
| 05/11/2005 | EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 05/11/2005 | EP1221952B1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 05/11/2005 | EP1069107B1 Fullerene derivatives |
| 05/11/2005 | CN1615284A Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 05/11/2005 | CN1200673C Antimicotic nail varnish composition |
| 05/10/2005 | US6891045 Method for producing carbonyldiimidazole |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040345A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | WO2005040138A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | WO2005040130A1 1h-imidazole derivatives as cannabinoid receptor modulators |
| 05/06/2005 | WO2005040129A2 Ccr3 receptor antagonists |
| 05/06/2005 | WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | WO2005040104A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | WO2005040097A1 Resolution of 3-amino alkylnitriles |
| 05/06/2005 | WO2005019240A3 Melanin concentrating hormone receptor antagonists |
| 05/06/2005 | WO2004113394A3 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |